sb 203580 has been researched along with Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, K; Olsen, CE; Selbo, PK; Weyergang, A | 1 |
| Bertino, JR; Li, W | 1 |
2 other study(ies) available for sb 203580 and Sarcoma
| Article | Year |
|---|---|
Circumvention of resistance to photodynamic therapy in doxorubicin-resistant sarcoma by photochemical internalization of gelonin.
Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Phospholipid Hydroperoxide Glutathione Peroxidase; Phosphorylation; Photochemotherapy; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Pyridines; Reactive Oxygen Species; Ribosome Inactivating Proteins, Type 1; Sarcoma | 2013 |
Fas-mediated signaling enhances sensitivity of human soft tissue sarcoma cells to anticancer drugs by activation of p38 kinase.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Caspase 9; Caspases; Cell Cycle; Cell Death; Cell Separation; Chalcone; Chalcones; Cytochrome c Group; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; fas Receptor; Flow Cytometry; Humans; Imidazoles; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Pyridines; Sarcoma; Signal Transduction; Soft Tissue Neoplasms; Time Factors; Tumor Cells, Cultured | 2002 |